Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -8.035% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCS(=O)(=O)N1CCC(C(=O)NCCCN2CCC(Cc3ccccc3)CC2)CC1
b Br.CC(C)(C)C(=O)CN1C2=NCCN2c2ccccc21
c CSCCC(NC(=O)c1ccccc1)C(=O)NCCc1ccc2c(c1)OCCO2
Answer: c. CSCCC(NC(=O)c1ccccc1)C(=O)NCCc1ccc2c(c1)OCCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCCC(NC(=O)c1ccccc1)C(=O)NCCc1ccc2c(c1)OCCO2
CSCCC(NC(=O)c1ccccc1)C(=O)NCCc1ccc2c(c1)OCCO2
N-[1-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)ethylamino]-4-methylsulfanyl-1-oxobutan-2-yl]benzamide